Menu
Back to Journals » Psoriasis: Targets and Therapy » Volume 8
Review
Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,524 | Dovepress* | 9,222+ | 1,376 | 10,598 | |
| PubMed Central* | 2,302 | 414 | 2,716 | ||
| Totals | 11,524 | 1,790 | 13,314 | ||
| *Since 29 August 2018 | |||||
View citations on PubMed Central and Google Scholar